230 related articles for article (PubMed ID: 30370820)
1. A Systematic Review and Meta-Analysis of Subsequent Malignant Neoplasm Risk After Radioactive Iodine Treatment of Thyroid Cancer.
Yu CY; Saeed O; Goldberg AS; Farooq S; Fazelzad R; Goldstein DP; Tsang RW; Brierley JD; Ezzat S; Thabane L; Goldsmith CH; Sawka AM
Thyroid; 2018 Dec; 28(12):1662-1673. PubMed ID: 30370820
[No Abstract] [Full Text] [Related]
2. Second primary malignancy risk after radioactive iodine treatment for thyroid cancer: a systematic review and meta-analysis.
Sawka AM; Thabane L; Parlea L; Ibrahim-Zada I; Tsang RW; Brierley JD; Straus S; Ezzat S; Goldstein DP
Thyroid; 2009 May; 19(5):451-7. PubMed ID: 19281429
[TBL] [Abstract][Full Text] [Related]
3. Risk of second primary breast cancer after radioactive iodine treatment in thyroid cancer: a systematic review and meta-analysis.
Zhang Y; Liang J; Li H; Cong H; Lin Y
Nucl Med Commun; 2016 Feb; 37(2):110-5. PubMed ID: 26513055
[TBL] [Abstract][Full Text] [Related]
4. Cancer Risk After Radioactive Iodine Treatment for Hyperthyroidism: A Systematic Review and Meta-analysis.
Shim SR; Kitahara CM; Cha ES; Kim SJ; Bang YJ; Lee WJ
JAMA Netw Open; 2021 Sep; 4(9):e2125072. PubMed ID: 34533571
[TBL] [Abstract][Full Text] [Related]
5. The Effect of Radioactive Iodine Therapy on Ovarian Function and Fertility in Female Thyroid Cancer Patients: A Systematic Review and Meta-Analysis.
Piek MW; Postma EL; van Leeuwaarde R; de Boer JP; Bos AME; Lok C; Stokkel M; Filipe MD; van der Ploeg IMC
Thyroid; 2021 Apr; 31(4):658-668. PubMed ID: 33012254
[No Abstract] [Full Text] [Related]
6. Risk and outcome of subsequent malignancies after radioactive iodine treatment in differentiated thyroid cancer patients.
Mei X; Yao X; Feng F; Cheng W; Wang H
BMC Cancer; 2021 May; 21(1):543. PubMed ID: 33980182
[TBL] [Abstract][Full Text] [Related]
7. Second primary malignancies induced by radioactive iodine treatment of differentiated thyroid carcinoma - a critical review and evaluation of the existing evidence.
Reinecke MJ; Ahlers G; Burchert A; Eilsberger F; Flux GD; Marlowe RJ; Mueller HH; Reiners C; Rohde F; van Santen HM; Luster M
Eur J Nucl Med Mol Imaging; 2022 Jul; 49(9):3247-3256. PubMed ID: 35320386
[TBL] [Abstract][Full Text] [Related]
8. Risk of primary breast cancer in patients with differentiated thyroid cancer undergoing radioactive iodine therapy: a systematic review and meta-analysis.
Nappi C; Klain M; Cantoni V; Green R; Piscopo L; Volpe F; Maurea S; Petretta M; Cuocolo A
Eur J Nucl Med Mol Imaging; 2022 Apr; 49(5):1630-1639. PubMed ID: 34820683
[TBL] [Abstract][Full Text] [Related]
9. A systematic review examining the effects of therapeutic radioactive iodine on ovarian function and future pregnancy in female thyroid cancer survivors.
Sawka AM; Lakra DC; Lea J; Alshehri B; Tsang RW; Brierley JD; Straus S; Thabane L; Gafni A; Ezzat S; George SR; Goldstein DP
Clin Endocrinol (Oxf); 2008 Sep; 69(3):479-90. PubMed ID: 18284643
[TBL] [Abstract][Full Text] [Related]
10. Rising incidence of second cancers in patients with low-risk (T1N0) thyroid cancer who receive radioactive iodine therapy.
Iyer NG; Morris LG; Tuttle RM; Shaha AR; Ganly I
Cancer; 2011 Oct; 117(19):4439-46. PubMed ID: 21432843
[TBL] [Abstract][Full Text] [Related]
11. Risk of second primary malignancy after radioactive iodine treatment for differentiated thyroid carcinoma.
Bhattacharyya N; Chien W
Ann Otol Rhinol Laryngol; 2006 Aug; 115(8):607-10. PubMed ID: 16944659
[TBL] [Abstract][Full Text] [Related]
12. Estimation of Second Primary Cancer Risk After Treatment with Radioactive Iodine for Differentiated Thyroid Carcinoma.
Corrêa NL; de Sá LV; de Mello RC
Thyroid; 2017 Feb; 27(2):261-270. PubMed ID: 27762670
[TBL] [Abstract][Full Text] [Related]
13. Association Between Radioactive Iodine Treatment for Pediatric and Young Adulthood Differentiated Thyroid Cancer and Risk of Second Primary Malignancies.
Pasqual E; Schonfeld S; Morton LM; Villoing D; Lee C; Berrington de Gonzalez A; Kitahara CM
J Clin Oncol; 2022 May; 40(13):1439-1449. PubMed ID: 35044839
[TBL] [Abstract][Full Text] [Related]
14. Timing of Radioactive Iodine Administration Does Not Influence Outcomes in Patients with Differentiated Thyroid Carcinoma.
Scheffel RS; Zanella AB; Dora JM; Maia AL
Thyroid; 2016 Nov; 26(11):1623-1629. PubMed ID: 27549175
[TBL] [Abstract][Full Text] [Related]
15. Dietary iodine restriction in preparation for radioactive iodine treatment or scanning in well-differentiated thyroid cancer: a systematic review.
Sawka AM; Ibrahim-Zada I; Galacgac P; Tsang RW; Brierley JD; Ezzat S; Goldstein DP
Thyroid; 2010 Oct; 20(10):1129-38. PubMed ID: 20860420
[TBL] [Abstract][Full Text] [Related]
16. Risk of Hematologic Malignancies After Radioiodine Treatment of Well-Differentiated Thyroid Cancer.
Molenaar RJ; Sidana S; Radivoyevitch T; Advani AS; Gerds AT; Carraway HE; Angelini D; Kalaycio M; Nazha A; Adelstein DJ; Nasr C; Maciejewski JP; Majhail NS; Sekeres MA; Mukherjee S
J Clin Oncol; 2018 Jun; 36(18):1831-1839. PubMed ID: 29252123
[TBL] [Abstract][Full Text] [Related]
17. Surgical Risk Prediction for Nasolacrimal Duct Obstruction in Radioactive Iodine-Treated Thyroid Cancer: A Nationwide Cohort Study.
Lee JY; Woo KI
Thyroid; 2022 May; 32(5):544-551. PubMed ID: 34894720
[No Abstract] [Full Text] [Related]
18. Radioactive Iodine Therapy Did Not Significantly Increase the Incidence and Recurrence of Subsequent Breast Cancer.
Ahn HY; Min HS; Yeo Y; Ma SH; Hwang Y; An JH; Choi HS; Keam B; Im SA; Park DJ; Park IA; Noh DY; Youn YK; Chung JK; Cho BY; Park SK; Park YJ
J Clin Endocrinol Metab; 2015 Sep; 100(9):3486-93. PubMed ID: 26147607
[TBL] [Abstract][Full Text] [Related]
19. Use of Radioactive Iodine for Thyroid Cancer and Risk of Second Primary Malignancy: A Nationwide Population-Based Study.
Teng CJ; Hu YW; Chen SC; Yeh CM; Chiang HL; Chen TJ; Liu CJ
J Natl Cancer Inst; 2016 Feb; 108(2):. PubMed ID: 26538627
[TBL] [Abstract][Full Text] [Related]
20. A systematic review of the gonadal effects of therapeutic radioactive iodine in male thyroid cancer survivors.
Sawka AM; Lea J; Alshehri B; Straus S; Tsang RW; Brierley JD; Thabane L; Rotstein L; Gafni A; Ezzat S; Goldstein DP
Clin Endocrinol (Oxf); 2008 Apr; 68(4):610-7. PubMed ID: 17973944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]